BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2008
View Archived Issues
Vx-001 telomerase vaccine immunogenic in advanced solid tumor patients
Read More
Proof-of-concept trial shows potential of atiprimod in neuroendocrine carcinoma
Read More
Data on activity of XL-647 in non-small cell lung cancer accumulates
Read More
Favorable phase III results with odanacatib in postmenopausal osteoporosis
Read More
Novel antipsoriatic agents imparted in recent University of Sunderland patent
Read More
Metabasis reports positive results from phase Ib clinical trial of MB-07811
Read More
Theratechnologies reports positive results from phase III clinical trial of tesamorelin
Read More
Aplindin effective alone and in combination with dexamethasone
Read More
Bavarian reports interim data from two phase I/II studies of MVA-BN-HER2
Read More
Euro Nippon Kayaku withdraws its MAA for Spanidin
Read More
Recent patents describe novel therapeutic agents for respiratory disorders
Read More
FDA lifts clinical hold on AeroLEF and clears phase II clinical trial
Read More
FDA approves Avodart in combination with tamsulosin for enlarged prostate
Read More
CureVac enters partnership with University of Florida to develop CV-9103 in prostate cancer
Read More
Forest announces results from CANVAS I and CANVAS II phase III studies of ceftaroline
Read More
First phase II study results of CK-1827452 in patients with heart failure
Read More
Merck provides update on U.S. regulatory status for MK-0524A and MK-0524B
Read More
Avontec reports results from a phase I study of AVT-02 UE for inflammatory skin diseases
Read More
NeuroSearch reports positive results from a phase II study in adult ADHD
Read More
Pharmaxis and the FDA agree on SPA for Bronchitol phase III registration trial
Read More
Phase II trial evaluates Reolysin in combination with paclitaxel and carboplatin
Read More
Welichem Biotech completes phase IIa WBI-1001 clinical trial in atopic dermatitis
Read More
FDA approves Velcade for injection in patients with multiple myeloma
Read More
Astellas submits sNDA in Japan for Prograf in ulcerative colitis
Read More